Layer 1

Patient harm prompts fresh calls to tackle stock shortages

Supply chain After a survey found some pharmacies are hit by six or more stock delays a week, with a direct impact on patient care, pharmacy leaders are renewing calls for the government to take action.

The government is facing fresh pressure to tackle stock shortages after a Pharmacy Voice survey uncovered reports of patient harm, distress and inconvenience due to medicines delays.

The survey, commissioned by Pharmacy Voice and undertaken by MEL Research, found that a quarter of the pharmacies randomly selected to participate had experienced six or more delays a week. The research found 457 reports of shortages across 106 UK pharmacies, which each spent two weeks recording supply chain issues, split over a two-month period.

Where delays did occur, a fifth of cases resulted in patients suffering distress, 12 per cent had a clinical impact and patients reported inconvenience in 44 per cent of incidents. The findings supported results from C+D's Stocks Survey 2011, which found that almost half of pharmacists had known a patient whose health had suffered in the 12 months leading up to the survey because of medicines shortages.

And the fresh reports prompted calls for action on the all-party pharmacy group (APPG) recommendations to tackle stock shortages, published in May, which the government is now "carefully considering".

"Patients are continuing to suffer harm and distress as a result of not being able to obtain vital medicines" Kevin Barron, APPG

More on stock shortages

Resolving stock shortages

Government must ‘get off its backside' says MP as       80 per cent of PCTs report stock shortages

Pharmacy can ‘force' DH's hand on stock shortages

Mike Holden, NPA chief executive and Pharmacy Voice spokesperson, said the level of patient distress reported was "intolerable". And Gareth Jones, a spokesperson for Pharmacy Voice, branded the findings unacceptable at a time when the NHS was focusing on patient experience.

"Patient experience is regarded as an important outcome in the NHS now, so we should regard stress and inconvenience as significant factors," Mr Jones said. "I don't think anyone can say the supply chain is acceptable as it is, and we've got to keep working to reduce the problems."

Pharmacy Voice renewed its calls for the government to take action on the shortages – both by enforcing its guidelines to deliver medicines within 24 hours of ordering and acting on recommendations made by the APPG. The recommendations included exempting medicines from EU free trade laws to cut back on exporting.

The APPG urged the government to take action, stressing that the problem "could not wait". "It has now been almost six months since we published our report into the matter, and yet patients are continuing to suffer harm and distress as a result of not being able to obtain vital medicines," said APPG chair Kevin Barron.

PSNC added weight to the concerns, saying it was continuing to receive reports of pharmacists struggling to obtain medicines, which had become "part of everyday life" for many.

"Pharmacies are spending far too much time sourcing medicines for patients… and many remain frustrated by the length of time it takes to source medicines through emergency supply routes," said PSNC head of support services Komal Patel.

Responding to the findings, the Department of Health (DH) said it was "carefully considering" the APPG recommendations, but stressed that the "vast majority" of patients received their medicines on time. It added that some delays were "inevitable" and urged pharmacists to follow its best practice guidance.

"If medicines aren't immediately available for patients, pharmacists should have contingency arrangements in place to obtain supplies from alternative sources where possible," a DH spokesperson said. "The government also maintains a buffer stock of certain essential medicines that can be released in emergency situations."

Expert comment

Martin Sawer, executive director of the British Association of Pharmaceutical Wholesalers, says stock shortages remain as damaging and time-consuming as ever

"The situation is like trying to keep a lid on a kettle. We're trying to manage stocks and even out supply over the month, and pharmacists are coping with the situation and spending time on it, but it's not satisfactory.

"The APPG pressure hasn't changed anything, particularly as everybody is waiting for ministers to reflect on the recommendations, which they promised to do before the end of the year. One would hope that Parliament puts pressure on the government to enforce the supply chain guidelines they published.

"We would reiterate that if the guidelines were followed appropriately, and buffer stocks were held in the wholesalers, with direct deliveries to pharmacies from manufacturers really only used as a ‘last resort', then a lot of the problems for pharmacists in obtaining stock would go away."

What impact do stock shortages have in your pharmacy?

Comment below or email us at [email protected] You can also find C+D on Twitter, LinkedIn and Facebook


Leon The Apothecary, Student

Quotas and stock shortages are the bane of my professional life.

Lance Roth, Manager

To Stephen Whitehead I would like to say this, that if you are of the belief/opinion that the Pharm Industry's priority has always been patient safety you live with your head in the clouds. Safety has been only but one of many priorities, and like any other company who is listed on the Stock Exchange, their main priority has always, and will always be the benefits to their stake holders. Like any retail chemist, the Industry is not a charity and profit will always trump patient care. THAT is what most of us pharmacists have to battle with on a daily basis! And the sad thing is that we are so not winning this war!
If you want to join this debate Sir, please do not insult our intelligence.

Greg Penhallow,

Pharmacy Voice’s survey does not reflect the problem at the heart of the branded medicines supply shortage issue.

Contrary to Pharmacy Voice’s claims, the primary cause of branded medicine shortages is the legal diversion of supply intended for UK patients to other European countries by a small number of pharmacists. This small number of pharmacists sell UK branded medicines abroad for profit, but they do so in irregular patterns and in high enough quantities to have a major impact on the supply chain.

Manufacturers already oversupply the UK market with on average an additional 15% - 30% more medicines than is necessary for UK patients, and even higher in certain cases. Further oversupplying the market by pharmaceutical companies will not solve supply shortages, but will simply encourage this minority of rogue pharmacists to order yet more UK branded medicines so that they can sell them abroad. This is not an academic point - one manufacturer received orders representative of 26 years’ worth of the UK requirement for one medicine within a five month period.

The pharmaceutical industry, pharmacists and wholesalers have been aware of the supply diversion problem for some time and all stakeholders contributed to the recent All Party Pharmacy Group’s enquiry in to supply shortages. After extensive evidence sessions the Group made a number of recommendations to the DH that aimed to ensure that patients are not in any way inconvenienced or harmed by the small number of wholesalers whose sole focus is profiteering. These recommendations are currently being considered by the DH.

The pharmaceutical industry’s priority is always patient safety. It is very concerning to hear that these incidents are occurring despite all the work being done by everyone in the supply chain and with Government. All members of the supply chain must put the UK patient ahead of their exporting interests.

Stephen Whitehead, Chief Executive, Association of the British Pharmaceutical Industry

Job of the week

Relief Pharmacist or store based Pharmacist
Mid Wales - Powys (Builth and Lland
Competitive Salary + Location Supplement and Benefits